Cargando…
New Insights in the Pathogenesis of Multiple Sclerosis—Role of Acrolein in Neuronal and Myelin Damage
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by an inappropriate inflammatory reaction resulting in widespread myelin injury along white matter tracts. Neurological impairment as a result of the disease can be attributed to immune-mediated injury...
Autores principales: | Tully, Melissa, Shi, Riyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821601/ https://www.ncbi.nlm.nih.gov/pubmed/24113583 http://dx.doi.org/10.3390/ijms141020037 |
Ejemplares similares
-
Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
por: Tully, Melissa, et al.
Publicado: (2018) -
Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury
por: Cho, Youngnam, et al.
Publicado: (2010) -
Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
por: Shi, Liangqin, et al.
Publicado: (2021) -
Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury
por: Park, Jonghyuck, et al.
Publicado: (2014) -
Critical role of mitochondrial aldehyde dehydrogenase 2 in acrolein sequestering in rat spinal cord injury
por: Herr, Seth A., et al.
Publicado: (2021)